Skip to main content
Top
Published in: Trials 1/2020

Open Access 01-12-2020 | Care | Study protocol

Brief motivational therapy versus enhanced usual care for alcohol use disorders in primary care in Chile: study protocol for an exploratory randomized trial

Authors: Nicolas A. Barticevic, Fernando Poblete, Soledad M. Zuzulich, Victoria Rodriguez, Laura Bradshaw

Published in: Trials | Issue 1/2020

Login to get access

Abstract

Background

Harmful alcohol use is a leading cause of global disability and death. However, increased detection and brief intervention capacity of more severe alcohol use disorders has not been accompanied by increased availability of treatment services. Incorporating treatment for such disorders into primary care is of paramount importance for improving access and health outcomes. This study aims to estimate the effectiveness of a Brief Motivational Treatment (BMT) applied in primary care for treatment of these disorders.

Methods

A parallel-group, single-blinded, severity-stratified, randomized clinical trial will test the superiority of BMT over enhanced usual care. Eligible participants will be those seeking treatment and who fulfill DSM-V criteria for alcohol use disorder and criteria for harmful alcohol use. With an estimated a loss to follow-up of 20%, a total of 182 participants will be recruited and equally randomized to each treatment group. The intervention group will receive an adaptation of the motivational enhancement therapy, as manualized in Project MATCH. This treatment consists of four 45-min sessions provided by a general psychologist with at least 3 years of primary care experience. The primary outcome is the change from baseline in the drinks per drinking day during the last 90 days, which will be captured using the Timeline Follow Back method. Secondary outcomes will describe the changes in alcohol use pattern, motivational status, and severity of the disorder.
All participants will be analyzed according to the group they were allocated, regardless of the treatment actually received. Mean differences (MD) will be computed for continuous outcomes and relative risks (RR) and RR reductions (RRR) for dichotomous results. Linear models will deliver the subgroup analyses. Missingness is assumed to be associated with the baseline alcohol use pattern and severity, so a multiple imputation method will be used to handle missing data.

Discussion

This trial aims to test the superiority of BMT over enhanced usual care with a reasonable superiority margin, over which the BMT could be further considered for incorporation into PC in Chile. Its pragmatic approach ultimately aims to inform policymakers about the benefit of including a brief psychosocial treatment into PC.

Trial registration

ClinicalTrials.gov NCT04345302. Registered on 28 April 2020
Appendix
Available only for authorised users
Literature
1.
go back to reference Organization WH. Global status report on alcohol and health 2018. Organization WH. Global status report on alcohol and health 2018.
2.
go back to reference Miller WR, Walters ST, Bennett ME. How effective is alcoholism treatment in the United States? J Stud Alcohol. 2001;62:211–20.CrossRef Miller WR, Walters ST, Bennett ME. How effective is alcoholism treatment in the United States? J Stud Alcohol. 2001;62:211–20.CrossRef
3.
go back to reference Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiat. 2008;165:179–87.CrossRef Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiat. 2008;165:179–87.CrossRef
4.
go back to reference Miller WR, Wilbourne PL. Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction. 2002;97:265–77.CrossRef Miller WR, Wilbourne PL. Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction. 2002;97:265–77.CrossRef
5.
go back to reference Kohn R, Saxena S, Levav I, Saraceno B. The treatment gap in mental health care. B World Health Organ. 2004;82:858–66. Kohn R, Saxena S, Levav I, Saraceno B. The treatment gap in mental health care. B World Health Organ. 2004;82:858–66.
6.
go back to reference Barticevic N, Margozzini P. How many people with harmful alcohol use are benefiting from face-to-face interventions in Chile? Addict Sci Clin Pract. 2018;13:1–16. Barticevic N, Margozzini P. How many people with harmful alcohol use are benefiting from face-to-face interventions in Chile? Addict Sci Clin Pract. 2018;13:1–16.
7.
go back to reference Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J. Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse. Subst Abus. 2007;28:7–30.CrossRef Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J. Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse. Subst Abus. 2007;28:7–30.CrossRef
8.
go back to reference Saitz R. Alcohol screening and brief intervention in primary care: absence of evidence for efficacy in people with dependence or very heavy drinking. Drug Alcohol Rev. 2010;29:631–40.CrossRef Saitz R. Alcohol screening and brief intervention in primary care: absence of evidence for efficacy in people with dependence or very heavy drinking. Drug Alcohol Rev. 2010;29:631–40.CrossRef
9.
go back to reference McCambridge J, Saitz R. Rethinking brief interventions for alcohol in general practice. BMJ. 2017;356:j116.CrossRef McCambridge J, Saitz R. Rethinking brief interventions for alcohol in general practice. BMJ. 2017;356:j116.CrossRef
10.
go back to reference Finn SW, Hammarberg A, Andreasson S. Treatment for alcohol dependence in primary care compared to outpatient specialist treatment—a randomized controlled trial. Alcohol Alcohol. 2018;53:376–85.CrossRef Finn SW, Hammarberg A, Andreasson S. Treatment for alcohol dependence in primary care compared to outpatient specialist treatment—a randomized controlled trial. Alcohol Alcohol. 2018;53:376–85.CrossRef
11.
go back to reference Brown RL, Saunders LA, Bobula JA, Mundt MP, Koch PE. Randomized-controlled trial of a telephone and mail intervention for alcohol use disorders: three-month drinking outcomes. Alcohol Clin Exp Res. 2007;31:1372–9.CrossRef Brown RL, Saunders LA, Bobula JA, Mundt MP, Koch PE. Randomized-controlled trial of a telephone and mail intervention for alcohol use disorders: three-month drinking outcomes. Alcohol Clin Exp Res. 2007;31:1372–9.CrossRef
12.
go back to reference Nadkarni A, Weobong B, Weiss HA, McCambridge J, Bhat B, Katti B, et al. Counselling for Alcohol Problems (CAP), a lay counsellor-delivered brief psychological treatment for harmful drinking in men, in primary care in India: a randomised controlled trial. Lancet. 2017;389:186–95.CrossRef Nadkarni A, Weobong B, Weiss HA, McCambridge J, Bhat B, Katti B, et al. Counselling for Alcohol Problems (CAP), a lay counsellor-delivered brief psychological treatment for harmful drinking in men, in primary care in India: a randomised controlled trial. Lancet. 2017;389:186–95.CrossRef
13.
go back to reference Project Match Research Group. Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol. 1997;58:7–29.CrossRef Project Match Research Group. Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol. 1997;58:7–29.CrossRef
14.
go back to reference Team UR. Effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT). BMJ. 2005;331:541.CrossRef Team UR. Effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT). BMJ. 2005;331:541.CrossRef
15.
go back to reference Miller WR, Rollnick S. Applications of motivational interviewing. Motivational interviewing: helping people change (3rd edition). New York: Guilford Press; 2013. Miller WR, Rollnick S. Applications of motivational interviewing. Motivational interviewing: helping people change (3rd edition). New York: Guilford Press; 2013.
16.
go back to reference VanBuskirk KA, Wetherell JL. Motivational interviewing with primary care populations: a systematic review and meta-analysis. J Behav Med. 2014;37:768–80.CrossRef VanBuskirk KA, Wetherell JL. Motivational interviewing with primary care populations: a systematic review and meta-analysis. J Behav Med. 2014;37:768–80.CrossRef
17.
go back to reference Ware JH, Hamel MB. Pragmatic trials — guides to better patient care? New Engl J Med. 2011;364:1685–7.CrossRef Ware JH, Hamel MB. Pragmatic trials — guides to better patient care? New Engl J Med. 2011;364:1685–7.CrossRef
18.
go back to reference American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013.CrossRef American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013.CrossRef
19.
go back to reference Miller WR, Center for Substance Abuse Treatment (U.S.), CDM Group, Inc. Enhancing motivation for change in substance abuse treatment. Rockville: Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment; 1999. Miller WR, Center for Substance Abuse Treatment (U.S.), CDM Group, Inc. Enhancing motivation for change in substance abuse treatment. Rockville: Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment; 1999.
20.
go back to reference Madson MB, Campbell TC. Measures of fidelity in motivational enhancement: a systematic review. J Subst Abus Treat. 2006;31:67–73.CrossRef Madson MB, Campbell TC. Measures of fidelity in motivational enhancement: a systematic review. J Subst Abus Treat. 2006;31:67–73.CrossRef
21.
go back to reference Rosa C, Ghitza U, Tai B. Selection and utilization of assessment instruments in substance abuse treatment trials: the National Drug Abuse Treatment Clinical Trials Network experience. Subst Abus Rehabil. 2012;3:81–9. Rosa C, Ghitza U, Tai B. Selection and utilization of assessment instruments in substance abuse treatment trials: the National Drug Abuse Treatment Clinical Trials Network experience. Subst Abus Rehabil. 2012;3:81–9.
22.
go back to reference Miller WR, Center for Substance Abuse Treatment (U.S.), CDM Group, Inc. Appendix B—screening and assessment instruments. Rockville: Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment; 1999. Miller WR, Center for Substance Abuse Treatment (U.S.), CDM Group, Inc. Appendix B—screening and assessment instruments. Rockville: Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment; 1999.
23.
go back to reference Miele GM, Carpenter KM, Cockerham MS, Trautman KD, Blaine J, Hasin DS. Substance Dependence Severity Scale (SDSS): reliability and validity of a clinician-administered interview for DSM-IV substance use disorders. Drug Alcohol Depend. 2000;59:63–75.CrossRef Miele GM, Carpenter KM, Cockerham MS, Trautman KD, Blaine J, Hasin DS. Substance Dependence Severity Scale (SDSS): reliability and validity of a clinician-administered interview for DSM-IV substance use disorders. Drug Alcohol Depend. 2000;59:63–75.CrossRef
24.
go back to reference Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 2016;12:38–48.CrossRef Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 2016;12:38–48.CrossRef
25.
go back to reference Andrade-González N, Fernández-Liria A. Spanish adaptation of the Working Alliance Inventory (WAI). Psychometric properties of the patient and therapist forms (WAI-P and WAI-T). Ann Psychol. 2015;31:524–10. Andrade-González N, Fernández-Liria A. Spanish adaptation of the Working Alliance Inventory (WAI). Psychometric properties of the patient and therapist forms (WAI-P and WAI-T). Ann Psychol. 2015;31:524–10.
26.
go back to reference Moyer A, Finney JW. Outcomes for untreated individuals involved in randomized trials of alcohol treatment. J Subst Abus Treat. 2002;23:247–52.CrossRef Moyer A, Finney JW. Outcomes for untreated individuals involved in randomized trials of alcohol treatment. J Subst Abus Treat. 2002;23:247–52.CrossRef
28.
go back to reference Poblete F, Barticevic NA, Zuzulic MS, Portilla R, Castillo-Carniglia Á, Sapag JC, et al. A randomized controlled trial of a brief intervention for alcohol and drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in primary health care in Chile. Addiction. 2017;112(8):1462–9.CrossRef Poblete F, Barticevic NA, Zuzulic MS, Portilla R, Castillo-Carniglia Á, Sapag JC, et al. A randomized controlled trial of a brief intervention for alcohol and drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in primary health care in Chile. Addiction. 2017;112(8):1462–9.CrossRef
29.
go back to reference Smedslund G, Berg RC, Hammerstrøm KT, Steiro A, Leiknes KA, Dahl HM, et al. Motivational interviewing for substance abuse. Cochrane Database Syst Rev. 2011;25:349–132. Smedslund G, Berg RC, Hammerstrøm KT, Steiro A, Leiknes KA, Dahl HM, et al. Motivational interviewing for substance abuse. Cochrane Database Syst Rev. 2011;25:349–132.
31.
go back to reference R Core Team. R: a language and environment for statistical computing. 2019. R Core Team. R: a language and environment for statistical computing. 2019.
32.
go back to reference Zhang E, Wu VQ, Chow S-C, Zhang HG. TrialSize: R functions in chapter 3,4,6,7,9,10,11,12,14,15. R package version 1.3; 2013. Zhang E, Wu VQ, Chow S-C, Zhang HG. TrialSize: R functions in chapter 3,4,6,7,9,10,11,12,14,15. R package version 1.3; 2013.
33.
go back to reference Sobell LC, Brown J, Leo GI, Sobell MB. The reliability of the Alcohol Timeline Followback when administered by telephone and by computer. Drug Alcohol Depend. 1996;42:49–54.CrossRef Sobell LC, Brown J, Leo GI, Sobell MB. The reliability of the Alcohol Timeline Followback when administered by telephone and by computer. Drug Alcohol Depend. 1996;42:49–54.CrossRef
34.
go back to reference Miele GM, Carpenter KM, Cockerham MS, Trautman KD, Blaine J, Hasin DS. Concurrent and predictive validity of the Substance Dependence Severity Scale (SDSS). Drug Alcohol Depend. 2000;59:77–88.CrossRef Miele GM, Carpenter KM, Cockerham MS, Trautman KD, Blaine J, Hasin DS. Concurrent and predictive validity of the Substance Dependence Severity Scale (SDSS). Drug Alcohol Depend. 2000;59:77–88.CrossRef
35.
go back to reference Vélez-Moreno A, González-Saiz F, Rojas AJ, Torrico-Linares E, Fernández-Calderón F, Ramírez-López J, et al. Reliability and validity of the Spanish version of the Substance Dependence Severity Scale. Eur Addict Res. 2014;21:39–46.CrossRef Vélez-Moreno A, González-Saiz F, Rojas AJ, Torrico-Linares E, Fernández-Calderón F, Ramírez-López J, et al. Reliability and validity of the Spanish version of the Substance Dependence Severity Scale. Eur Addict Res. 2014;21:39–46.CrossRef
36.
go back to reference Miller WR, Tonigan JS, Longabaugh R. The drinker inventory of consequences (DrInC); 1995.CrossRef Miller WR, Tonigan JS, Longabaugh R. The drinker inventory of consequences (DrInC); 1995.CrossRef
37.
go back to reference Miller WR, Tonigan JS. Assessing drinkers’ motivation for change: the Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES). Psychol Addict Behav. 1996;10:81–9.CrossRef Miller WR, Tonigan JS. Assessing drinkers’ motivation for change: the Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES). Psychol Addict Behav. 1996;10:81–9.CrossRef
38.
go back to reference Group1 PMR. Matching alcoholism treatments to client heterogeneity: project MATCH three-year drinking outcomes. Alcohol Clin Exp Res. 1998;22:1300–11. Group1 PMR. Matching alcoholism treatments to client heterogeneity: project MATCH three-year drinking outcomes. Alcohol Clin Exp Res. 1998;22:1300–11.
39.
go back to reference Magill M, Kiluk BD, McCrady BS, Tonigan JS, Longabaugh R. Active ingredients of treatment and client mechanisms of change in behavioral treatments for alcohol use disorders: progress 10 years later. Alcohol Clin Exp Res. 2015;39:1852–62.CrossRef Magill M, Kiluk BD, McCrady BS, Tonigan JS, Longabaugh R. Active ingredients of treatment and client mechanisms of change in behavioral treatments for alcohol use disorders: progress 10 years later. Alcohol Clin Exp Res. 2015;39:1852–62.CrossRef
Metadata
Title
Brief motivational therapy versus enhanced usual care for alcohol use disorders in primary care in Chile: study protocol for an exploratory randomized trial
Authors
Nicolas A. Barticevic
Fernando Poblete
Soledad M. Zuzulich
Victoria Rodriguez
Laura Bradshaw
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Care
Published in
Trials / Issue 1/2020
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-020-04589-4

Other articles of this Issue 1/2020

Trials 1/2020 Go to the issue